NCT01404598 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male


Sponsors: NicOx	Phases: Phase I
Indications	Acronym:
Pharmacokinetics
Age Groups: Adult	Gender: Male
Names: Drug: naproxcinod 750 bid Drug: naproxcinod 3000 mg od Drug: naproxen 500 mg bid	Enrollment: 24

Additional information about NCT01404598.